PCR-based pre-emptive therapy of cytomegalovirus infections after allogeneic stem cell transplantation with sequential intravenous ganciclovir foscarnet and oral ganciclovir.

被引：0
|
作者：
Chakrabarti, S [1 ]
Collingham, K [1 ]
Pillay, D [1 ]
Milligan, DW [1 ]
机构：
[1] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1999年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
119
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
    Nakamura, R
    Cortez, K
    Solomon, S
    Battiwalla, M
    Gill, VJ
    Hensel, N
    Childs, R
    Barrett, AJ
    BONE MARROW TRANSPLANTATION, 2002, 30 (04) : 235 - 242
  • [22] High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
    R Nakamura
    K Cortez
    S Solomon
    M Battiwalla
    VJ Gill
    N Hensel
    R Childs
    AJ Barrett
    Bone Marrow Transplantation, 2002, 30 : 235 - 242
  • [23] Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience
    Manteiga, R
    Martino, R
    Sureda, A
    Labeaga, R
    Brunet, S
    Sierra, J
    Rabella, N
    BONE MARROW TRANSPLANTATION, 1998, 22 (09) : 899 - 904
  • [24] Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience
    R Manteiga
    R Martino
    A Sureda
    R Labeaga
    S Brunet
    J Sierra
    N Rabella
    Bone Marrow Transplantation, 1998, 22 : 899 - 904
  • [25] Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation
    M Yanada
    K Yamamoto
    N Emi
    T Naoe
    R Suzuki
    H Taji
    H Iida
    T Shimokawa
    A Kohno
    S Mizuta
    F Maruyama
    A Wakita
    K Kitaori
    K Yano
    M Hamaguchi
    N Hamajima
    Y Morishima
    Y Kodera
    H Sao
    Y Morishita
    Bone Marrow Transplantation, 2003, 32 : 801 - 807
  • [26] Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT):: a randomised study
    Moretti, S
    Zikos, P
    Van Lint, MT
    Tedone, E
    Occhini, D
    Gualandi, F
    Lamparelli, T
    Mordini, N
    Berisso, G
    Bregante, S
    Bruno, B
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 1998, 22 (02) : 175 - 180
  • [27] Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation
    Yanada, M
    Yamamoto, K
    Emi, N
    Naoe, T
    Suzuki, R
    Taji, H
    Iida, H
    Shimokawa, T
    Kohno, A
    Mizuta, S
    Maruyama, F
    Wakita, A
    Kitaori, K
    Yano, K
    Hamaguchi, M
    Hamajima, N
    Morishima, Y
    Kodera, Y
    Sao, H
    Morishita, Y
    BONE MARROW TRANSPLANTATION, 2003, 32 (08) : 801 - 807
  • [28] Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study
    S Moretti
    P Zikos
    MT Van Lint
    E Tedone
    D Occhini
    F Gualandi
    T Lamparelli
    N Mordini
    G Berisso
    S Bregante
    B Bruno
    A Bacigalupo
    Bone Marrow Transplantation, 1998, 22 : 175 - 180
  • [29] Foscarnet as single agent pre-emptive treatment of cytomegalovirus reactivation after T-cell depleted allogeneic haematopoietic stem cell transplantation
    Ciceri, F
    Lunghi, F
    Pescarollo, A
    Guggiari, E
    Bonini, C
    Servida, P
    Callegaro, L
    Bernardi, M
    Crippa, F
    Bordignon, C
    Bregni, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S319 - S319
  • [30] Prospective Study of Oral Valganciclovir for Pre-Emptive Therapy of Cytomegalovirius After Allogeneic Stem Cell Transplantation.
    De La Camara, Rafael
    Vazquez, Lourdes
    Lopez, Javier
    Solano, Carlos
    Serrano, David
    Gracia-Noblejas, Ana
    Ribera, Josep-Maria
    Ferra, Christelle
    BLOOD, 2009, 114 (22) : 479 - 480
12345